CLAYTON, Mo. — A Missouri judge on Wednesday temporarily halted enforcement of a first-of-its-kind rule that restricts access to gender-affirming health care for transgender kids and adults, just hours before it was set to take effect.
The rule instated by Republican Attorney General Andrew Bailey places requirements on both minors and adults before they would be allowed to receive gender-affirming treatments, such as puberty blockers or hormones. It was set to take effect Thursday, but transgender Missourians and health care providers sued to stop it from being enforced.
St. Louis County Circuit Judge Ellen Ribaudo said Wednesday that she would like more time to review the matter before deciding whether to issue a temporary restraining order. She delayed implementation of the rule until 5 p.m. Monday, saying she anticipates she will issue a ruling before then.
Bailey has touted the rule as a way to shield minors from what he describes as experimental medical treatments, though puberty blockers and sex hormones have been prescribed for decades. But the lawsuit claims that Bailey sidestepped the GOP-led Legislature and acted beyond his authority in attempting to regulate gender-affirming health care under the state’s consumer-protection laws.
Attorney Tony Rothert with the American Civil Liberties Union of Missouri told Ribaudo at a court hearing Wednesday that the regulations “will cause immediate, severe and potentially irreparable harm” for people who could lose access to medications that include puberty blockers and sex hormones.
He and other attorneys said that transgender people who can’t get gender-affirming care are at risk of suicide.
Assistant Attorney General Joshua Divine argued that Bailey’s order does not ban gender-affirming care.
The rule will require people to have experienced an “intense pattern” of documented gender dysphoria for three years and to have received at least 15 hourly sessions with a therapist over at least 18 months before receiving puberty blockers, hormones, surgery or other treatment. Patients also must first be screened for autism and “social media addiction,” and any psychiatric symptoms from mental health issues would have to be treated and resolved.
Some people would be able to maintain their prescriptions while undergoing required assessments.
Divine said the rule provides “basic procedural guardrails.” He cited studies showing that a high percentage of kids seeking to transition are dealing with mental health issues. He said that rather than transition they should undergo “talk therapy.”
Those suing argue Bailey sidestepped the GOP-led Legislature and acted beyond his authority,
“We don’t allow attorneys general to legislate, and we don’t allow them to play doctor,” Rothert said.
Emily Wales, president and CEO of Planned Parenthood Great Plains, said that with the delay, transgender and non-binary Missourians will still be able to receive treatment on Thursday. “And while this is temporary relief, our patients always deserve the highest standard of care, without the intervention of politicians who have no grasp of medicine,” she said.
Bailey issued the restrictions following an investigation he launched in February into the Washington University Transgender Center at St. Louis Children’s Hospital. The investigation was prompted by a former employee who alleged the center was providing children with gender-affirming care without informed consent, not enough individualized case review and wraparound mental health services. An internal review by the university found no misconduct and determined that the former employee’s claims were unsubstantiated.
Bailey’s efforts to crack down on gender-affirming health care come as Republican lawmakers across the country have proposed hundreds of laws aimed at transgender people. At least 13 states have enacted laws restricting or banning gender-affirming care for minors.
The Food and Drug Administration approved puberty blockers 30 years ago to treat children with precocious puberty — a condition that causes sexual development to begin much earlier than usual. Sex hormones — synthetic forms of estrogen and testosterone — were approved decades ago to treat hormone disorders or as birth control pills.
The FDA has not approved the medications specifically to treat gender-questioning youth. But they have been used for many years for that purpose “off label,” a common and accepted practice for many medical conditions. Doctors who treat transgender patients say those decades of use mean the treatments are not experimental.
Critics have raised concerns about children changing their minds. Yet the evidence suggests detransitioning is not as common as opponents of transgender medical treatment for youth contend, though few studies exist.
Missouri House Minority Leader Crystal Quade said Wednesday that she sent letters to President Joe Biden and the Center for Medicare and Medicaid Services earlier this week, asking for an executive order to extend coverage for Missourians who seek gender-affirming care in other states. She also sent letters to the governors of Kansas and Illinois, asking that their health care systems accept Missouri patients for such care.